NOVAVAX INC (NVAX) › Operating Cash FlowNOVAVAX INC (NVAX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$32.83M2010: -$32.85M2011: -$23.63M2012: -$18.23M2015: -$126.09M2016: -$258.77M2017: -$144.48M2018: -$184.82M2019: -$136.62M2020: -$42.54M2021: $322.95M2022: -$415.94M2023: -$713.97M2024: -$87.26M2025: -$244.63M-$244.63M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$244.63M-180.3%2024-$87.26M+87.8%2023-$713.97M-71.7%2022-$415.94M-228.8%2021$322.95M+859.1%2020-$42.54M+68.9%2019-$136.62M+26.1%2018-$184.82M-27.9%2017-$144.48M+44.2%2016-$258.77M-105.2%2015-$126.09M—2012-$18.23M+22.9%2011-$23.63M+28.1%2010-$32.85M-0.1%2009-$32.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share